189 related articles for article (PubMed ID: 19318952)
1. Reply to 'HES 130/0.4 (Voluven) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial'.
Standl T
Eur J Anaesthesiol; 2009 Aug; 26(8):702-4. PubMed ID: 19318952
[No Abstract] [Full Text] [Related]
2. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch.
Gandhi SD; Weiskopf RB; Jungheinrich C; Koorn R; Miller D; Shangraw RE; Prough DS; Baus D; Bepperling F; Warltier DC
Anesthesiology; 2007 Jun; 106(6):1120-7. PubMed ID: 17525586
[TBL] [Abstract][Full Text] [Related]
3. [Coagulation changes during aortofemoral bifurcation bypass: is volume and plasma substitution possible with hydroxyethyl starch alone?].
von Sommoggy S; Fraunhofer J; Jelen-Esselborn S; Stemberger A
Anaesthesist; 1990 Jul; 39(7):353-60. PubMed ID: 1696795
[TBL] [Abstract][Full Text] [Related]
4. Six percent hydroxyethyl starch 130/0.4 (Voluven®) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients.
Van der Linden P; De Villé A; Hofer A; Heschl M; Gombotz H
Anesthesiology; 2013 Dec; 119(6):1296-309. PubMed ID: 23934169
[TBL] [Abstract][Full Text] [Related]
5. Is hydroxyethyl starch safe in brain injury?
Haynes GR
Anesth Analg; 2004 Aug; 99(2):620; author reply 620-2. PubMed ID: 15271753
[No Abstract] [Full Text] [Related]
6. A total balanced volume replacement strategy using a new balanced hydoxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery.
Boldt J; Schöllhorn T; Münchbach J; Pabsdorf M
Eur J Anaesthesiol; 2007 Mar; 24(3):267-75. PubMed ID: 17054812
[TBL] [Abstract][Full Text] [Related]
7. HES 130/0.4 (Voluven) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial.
Standl T; Lochbuehler H; Galli C; Reich A; Dietrich G; Hagemann H
Eur J Anaesthesiol; 2008 Jun; 25(6):437-45. PubMed ID: 18339212
[TBL] [Abstract][Full Text] [Related]
8. Voluven, a new colloid solution.
Mizzi A; Tran T; Karlnoski R; Anderson A; Mangar D; Camporesi EM
Anesthesiol Clin; 2011 Sep; 29(3):547-55. PubMed ID: 21871410
[TBL] [Abstract][Full Text] [Related]
9. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials.
Kozek-Langenecker SA; Jungheinrich C; Sauermann W; Van der Linden P
Anesth Analg; 2008 Aug; 107(2):382-90. PubMed ID: 18633012
[TBL] [Abstract][Full Text] [Related]
10. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
[TBL] [Abstract][Full Text] [Related]
11. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass.
Choi YS; Shim JK; Hong SW; Kim JC; Kwak YL
Minerva Anestesiol; 2010 Aug; 76(8):584-91. PubMed ID: 20661198
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European Prospective Multicenter Observational Postauthorization Safety Study (PASS).
Sümpelmann R; Kretz FJ; Gäbler R; Luntzer R; Baroncini S; Osterkorn D; Haeger MC; Osthaus WA
Paediatr Anaesth; 2008 Oct; 18(10):929-33. PubMed ID: 18647272
[TBL] [Abstract][Full Text] [Related]
13. Volume therapy in cardiac surgery: are Americans different from Europeans?
Boldt J
J Cardiothorac Vasc Anesth; 2006 Feb; 20(1):98-105. PubMed ID: 16458227
[No Abstract] [Full Text] [Related]
14. Effect of albumin and Hespan on rodent hepatocyte function after hemorrhagic shock and sepsis.
Vlahos AL; Crawford RS; Matthew HT; Ledgerwood AM; Lucas CE
J Trauma; 2005 Sep; 59(3):583-8. PubMed ID: 16361899
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyethylstarch supplementation in burn resuscitation--a prospective randomised controlled trial.
Vlachou E; Gosling P; Moiemen NS
Burns; 2010 Nov; 36(7):984-91. PubMed ID: 20558004
[TBL] [Abstract][Full Text] [Related]
16. How possibly are we to choose albumin or hydroxyethyl starch?
Hanna BD
Crit Care Med; 2009 Feb; 37(2):788-9. PubMed ID: 19325392
[No Abstract] [Full Text] [Related]
17. The dud cigar?--Cochrane collaboration and the saga of human albumin.
Bell E
Adverse Drug React Toxicol Rev; 1999 Aug; 18(3):149-63. PubMed ID: 10592836
[No Abstract] [Full Text] [Related]
18. Haemodilution induced by hydroxyethyl starches 130/0.4 is similar in septic and non-septic patients.
Meyer P; Pernet P; Hejblum G; Baudel JL; Maury E; Offenstadt G; Guidet B
Acta Anaesthesiol Scand; 2008 Feb; 52(2):229-35. PubMed ID: 18034867
[TBL] [Abstract][Full Text] [Related]
19. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4.
Hanart C; Khalife M; De Villé A; Otte F; De Hert S; Van der Linden P
Crit Care Med; 2009 Feb; 37(2):696-701. PubMed ID: 19114887
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients.
Friedman G; Jankowski S; Shahla M; Gomez J; Vincent JL
J Clin Anesth; 2008 Nov; 20(7):528-33. PubMed ID: 19019650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
